Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
Shanghai Henlius Biotech
St. Jude Children's Research Hospital
MacroGenics
Adaptimmune
City of Hope Medical Center
Innate Pharma
Novartis
Bayer
OncoNano Medicine, Inc.
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
LG Chem
West China Hospital
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
Bolt Biotherapeutics, Inc.
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
MacroGenics
Sichuan Baili Pharmaceutical Co., Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Pfizer
Asher Biotherapeutics, Inc.
Pfizer
MacroGenics
Toray Industries, Inc
Numab Therapeutics AG
University of Virginia
Genentech, Inc.
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Thomas Jefferson University
Turnstone Biologics, Corp.